About the Company
We do not have any company description for T2 Biosystems, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
186
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on T2 Biosystems, Inc.
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing ...
By offering real-time insights and targeted treatment information, T2 Biosystems and Prxcision, Inc. aim to reduce the burden of AMR, helping healthcare systems across the United States take a ...
T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial ...
LEXINGTON, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it ...
T2 Biosystems to Report Second Quarter 2024 Financial Results and ...
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today ...
T2 Biosystems Enhances Governance and Leadership Stability
T2 Biosystems, Inc. held its annual meeting of stockholders, where key corporate governance matters were addressed, including the approval of an amendment to the 2014 Incentive Award Plan.
T2 Biosystems Announces Extension of Multi-Year Capital ... - Nasdaq
--T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year capital equipment supplier agreement with ...
T2 Biosystems Inc. Company & People | 0A57 | Barron's
0.01 10.70% Jun 6, 2025 12:00 a.m. BST About T2 Biosystems Inc. T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens.
T2 Biosystems Inc. (TTOO) - News - Insider Monkey
T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript Operator: Good day, everyone. And welcome to the T2 Biosystems Preliminary Fourth Quarter and Full Year 2023 Results Conference Call.
T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript
T2 Biosystems, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here ). Operator: Good day, everyone.
T2 Biosystems reports Q2 loss per share $0.58 | Reuters
* T2 Biosystems Inc says research revenue is expected to be comparable to what was realized in Q2 of 2016 * Q3 earnings per share view $-0.54, revenue view $2.2 million -- Thomson Reuters I/B/E/S ...
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing ...
Investor Contacts: Philip Trip Taylor, Gilmartin Group ir@T2Biosystems.com 415-937-5406 Prxcision, Inc. info@pRxcision.com 518-631-8191 Source: T2 Biosystems, Inc. 2024 GlobeNewswire, Inc.
T2 Biosystems Announces Extension of Multi-Year Capital Equipment ...
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. Provided by GlobeNewswire Dec 16, 2024 6:00am ...
Similar Companies
Loading the latest forecasts...